Co-Developed OCT Spectroscopy Device Moving to Clinical Testing

Kent Imaging announced today that an OCT spectroscopy device, co-developed with the National Research Council of Canada (NRC), is moving to clinical testing. The completed new technology is being transported to a Toronto hospital to begin the first stage of clinical testing.

Italian Research Group Initiate Study

An Italian research group has submitted a protocol which will use the Kent Camera in an upcoming study to examining the benefits of hyperbaric oxygen therapy in venous ulcers. The study will recruit approximately 80 patients with venous ulcers. The Kent Camera will be used to non-invasively detect levels of oxy-hemoglobin and deoxy-hemoglobin in the superficial tissue.